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Abstract
Objective This study aimed to compare the health-related
quality of life (HRQOL) in patients with end-stage renal
disease (ESRD) treated with continuous ambulatory peri-
toneal dialysis (CAPD) and automated peritoneal dialysis
(APD) in Singapore.
Methods The data used in this study were from two cross-
sectional surveys of ESRD patients. HRQOL was assessed
using the Kidney Disease Quality of Life (KDQOL) instru-
ment. Socio-demographic characteristics and clinical datawere
collected. The physical component summary (PCS) andmental
component summary (MCS) scores, kidney disease component
summary (KDCS) score and its three scales (symptoms, effects,
burden), and one health utility score [EuroQol 5-dimension
(EQ-5D)] were calculated and compared between CAPD and
APD using multivariate linear regression.
Results In total, 266 patients were included, with 145 on
CAPD (mean age 60.8 years) and 121 on APD (mean age
57.4 years). After adjustment for all variables collected,
APD patients had significant higher scores in PCS and
KDQOL symptoms than CAPD patients, suggesting that
APD was associated with better physical health and milder
dialysis-related symptoms.
Conclusion The HRQOL of CAPD and APD patients was
largely equivalent in Singapore, but APD patients seemed
to experience better physical health and be less bothered by
dialysis-related symptoms.
Key Points for Decision Makers
Peritoneal dialysis (PD) has been used as a practical
and widespread alternative to conventional
hemodialysis (HD) for end-stage renal disease
(ESRD).
There are two forms of PD, continuous ambulatory PD
(CAPD) and automated PD (APD). It has been shown
that the clinical outcomes for these two PD modalities
are comparable, so evidence on health-related quality
of life (HRQOL) is important in guiding nephrologists
and patients in their choice of PD modality.
The HRQOL of CAPD and APD patients was largely
equivalent in Singapore, but APD patients seemed to
experience better physical health and be less
bothered by dialysis-related symptoms.
1 Introduction
Peritoneal dialysis (PD) has been used as a practical and
widespread alternative to conventional hemodialysis (HD)
for end-stage renal disease (ESRD) because of its
& K. Griva
psygk@nus.edu.sg
1 Manchester Centre for Health Economics, University of
Manchester, Manchester, UK
2 Saw Swee Hock School of Public Health, National University
of Singapore, Singapore, Singapore
3 Division of Nephrology, University Medicine Cluster,
National University Health System, Singapore, Singapore
4 Department of Psychology, Faculty of Arts and Social
Sciences, National University of Singapore, Singapore,
Singapore
5 Department of Renal Medicine, Singapore General Hospital,
Singapore, Singapore
PharmacoEconomics Open
DOI 10.1007/s41669-017-0046-z
advantages over HD, e.g., lower costs [1] and increased
flexibility in lifestyle [2]. But it remains largely underuti-
lized in most settings [3].
There are two forms of PD, continuous ambulatory PD
(CAPD), which involves performing the PD exchanges
manually, and automated PD (APD), which refers to all
forms of PD using a mechanical device to assist the
delivery and drainage of dialysate. It has been shown that
the clinical outcomes for these two PD modalities are
comparable [4, 5], so evidence on health-related quality of
life (HRQOL) is important to contribute to guiding
nephrologists and patients in their choice of PD modality.
In the provision of healthcare, HRQOL is commonly
evaluated, as it provides a good measure of treatment
effectiveness by revealing how well an individual is
functioning upon treatment [6]. For ESRD patients,
HRQOL is an important predictor of clinical outcomes, and
poor HRQOL could independently predict death and hos-
pitalization of dialysis patients [7, 8]. As the majority of
old and frail patients undergoing dialysis are unlikely to
receive kidney transplantation and would most likely
remain in dialysis until the end of life, the importance of
evaluating HRQOL is even more salient [9]. However,
previous work of HRQOL outcomes for PD modalities has
produced mixed evidence [10–12]. Furthermore, although
there has been an exponential increase in HRQOL research
in PD patients with Asian origin or in an Asian setting,
most work has mainly compared PD with HD and has not
been across PD modalities [2, 13, 14].
Therefore, this study aimed to evaluate HRQOL
between PD modalities and to explore factors which could
affect their HRQOL.
2 Methods
2.1 Patients and Data
Data used in this study were from two cross-sectional
surveys, conducted between 2009 [15] and 2013 [16].
Participants were recruited from the PD center of Singa-
pore General Hospital between 2009 and 2011 and from
the renal center of the National University Hospital
between 2012 and 2013. In both surveys, patients were
approached by trained interviewers while awaiting con-
sultation with a nephrologist. HRQOL data were collected
using the kidney disease-specific HRQOL instrument
Kidney Disease Quality of Life-Short Form (KDQOL-SF)
in the first survey and its abridged version, the 36-item
KDQOL (KDQOL-36), in the second survey, respectively.
Socio-demographic characteristics were self-reported, and
clinical data including co-morbidities measured using the
Charlson Comorbidity Index (CCI), serum albumin and
hemoglobin, dialysis vintage (i.e., time on dialysis),
dependency status (i.e., self-care/assisted) and dialysis
adequacy (i.e., Kt/V) were retrieved from medical records.
Patients were included if they were aged C 21-year-old,
on PD C 3 months, and able to communicate verbally and
provide informed consent. This study was approved by the
Institutional Review Board of the National University
Health System, Singapore.
2.2 Measures
KDQOL-SF and KDQOL-36 are two commonly used
instruments developed specifically for individuals with
kidney disease and on dialysis [17]. Both instruments have
been validated in ESRD patients in Singapore [18, 19].
KDQOL-SF includes Short Form-36 (SF-36) and 43 kidney
disease-specific items; the KDQOL-36 contains a subset of
the KDQOL-SF items, with Short Form-12 (SF-12) and 24
disease-specific items. Two summary scores, physical
component summary (PCS) and mental component sum-
mary (MCS), can be calculated from SF-12, and the disease-
specific part generates three kidney disease-specific scales,
i.e., symptoms, effects, and burden, and a kidney disease
component summary (KDCS) score by averaging the three
disease-specific subscales [20]. The EuroQol 5-dimension
(EQ-5D) health utility score can be obtained from SF-12
using an established mapping function [21], and it has been
demonstrated to be valid and sensitive in Singaporean dial-
ysis patients [16]. For summary scores and health utility,
higher scores represent better HRQOL, and for disease-
specific scales, higher scores represent fewer/milder symp-
toms, effects or burden due to kidney disease and dialysis.
2.3 Statistical Analysis
The socio-demographic and clinical characteristics were
compared first, and then the three summary scores (PCS,
MCS, and KDCS), three disease-specific scales and one
health utility score (EQ-5D) were compared between
patients with CAPD and those with APD. In the subsequent
multivariate linear regression, all factor variables were
coded into categorical variables in case the association was
not linear and then entered into seven models, one for each
of the HRQOL scores, regardless of their statistical sig-
nificance. All analyses were performed using STATA 14.0,
with p\ 0.05 being considered significant.
3 Results
A total of 266 patients were included, with 145 on CAPD
and 121 on APD. Patients’ mean [standard deviation (SD)]
age was 59.3 (12.5) years, with 45.5% male, 74.4%
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Chinese, 80.8% having secondary or lower education,
71.1% married, and 88.3% living in a public residence. The
mean (SD) CCI was 5.08 (1.67), and mean (SD) serum
albumin and hemoglobin levels were 30.3 (5.6) g/l and 10.9
(1.69) g/dl, respectively. For dialysis parameters, the mean
(SD) dialysis vintage was 3.55 (3.28) years, and the mean
(SD) Kt/V value was 2.33 (0.88) per week.
No significant difference was observed in gender, eth-
nicity, marital status, housing type, co-morbidity, albumin
level, hemoglobin level, and dialysis adequacy between
CAPD and APD patients. But APD patients were younger
than CAPD patients (mean age 57.4 vs. 60.8 years) and
there were more individuals with high education, under-
going assisted dialysis, and with shorter dialysis vintage in
the APD group. There was no significant difference in the
QOL scores, with the exception that APD patients had
higher KDQOL symptoms scores than CAPD patients
(76.0 vs. 69.8). Full characteristics and QOL scores are
shown in Table 1.
In multivariate analyses, APD was significantly associ-
ated with higher PCS and KDQOL symptoms scores,
indicating patients had better physical health and milder
dialysis-related symptoms (Table 2). We also found the
following factors significantly associated with higher
HRQOL scores (Table 2): young or old age, high albumin
level, self-care dialysis and low dialysis adequacy.
4 Discussion
In view of the lack of clear evidence showing the advan-
tage of one PD modality in clinical outcomes, a compar-
ison of HRQOL between CAPD and APD patients would
contribute to guiding the patient’s choice and provide
evidence for future cost-effectiveness assessment of PD
treatments. Few studies have investigated this topic, and
results are conflicting. De Wit et al. observed better mental
health in APD patients [10], while Bro et al. found no
difference in both physical and mental health [12].
Regarding the kidney disease-specific QOL, one previous
study of incident PD patients showed that APD had
advantages in KDQOL symptoms at 1 month, but signifi-
cance disappeared at 12 months [22]. In our study, the
HRQOL of CAPD and APD were almost equivalent, but
physical health and KDQOL symptoms were in favor of
APD.
The better physical health and fewer/milder symptoms
of APD patients may be mainly explained by the nature of
each PD modality. CAPD typically requires patients to
manually perform exchanges of dialysate fluid four to five
times a day, whereas APD is usually applied at night when
the patient is asleep using an automated machine. The great
time requirements of manual CAPD exchanges and
additional abdominal weight due to dwelling dialysate in
between the CAPD exchanges may be more likely to cause
discomfort and more interruptions to daily activities, hence
impacting HRQOL. In contrast, APD being an overnight
procedure entails no dialysate weight bearing and allows
more flexibility during the day for patients to pursue work,
family and daily activities [23], which would be associated
with better HRQOL. Also, compared to the manual
exchanges in CAPD, the use of a dialysis machine in APD
may lead to increased compliance with the prescribed PD
regime and hence better disease management, which may
in turn contribute to higher physical HRQOL. On the other
hand, we could not rule out the possibility that the study
participants may have been self-selected for better out-
comes such as milder dialysis-related symptoms since our
study cohort comprised prevalent PD patients with a mean
dialysis vintage over 3 years. The health utility measured
by the EQ-5D index showed a very small difference
between CAPD and APD patients, suggesting that the
relative cost-effectiveness of these two PD modalities in
Singapore would be mainly determined by their survival
outcomes and associated costs.
We also observed the impact of demographic, clinical
and dialysis-related characteristics rather than PD modality
itself on HRQOL. First, the impact of age on physical
health was non-linear, with the middle-aged showing worse
QOL, but old patients reporting comparable results to the
young. A similar trend has been observed in previous
studies [2, 24]. This may be due to the greater adaptation to
chronic dialysis and old patients’ lower expectations
regarding their health. Second, high albumin level was
associated with higher scores in PCS, MCS, KDQOL
effects and health utility index. These associations make
good sense from the clinical perspective. A low albumin
may reflect malnutrition, and it is known to be strongly
related to higher risk for mortality and morbidity in dialysis
patients [2, 25]. Thus, it would be expected to be associated
with poorer HRQOL. Third, self-care patients reported
better physical health and better health utility measured
using EQ-5D, in line with the previous study [9]. This
result was not surprising because patients having physical
difficulties such as decreased vision and strength would be
more likely to use assisted PD; however, the impact of
these physical difficulties cannot be adjusted by the anal-
yses of this study. Last, higher dialysis adequacy was
associated with lower QOL scores, different from the
previous study showing the positive correlation of Kt/V
and HRQOL [26]. In clinical practice, a dialysis adequacy
target value is set to reduce the mortality risk [27], but to
reach this target, patients might experience adverse effects
and the increased amount of time needed to perform the
exchanges is less acceptable to patients [27]. These factors
might adversely affect QOL in PD patients.
HRQOL in Patients Treated with CAPD and APD in Singapore
This study has several limitations. First, the HRQOL
data were from two different versions of the KDQOL,
which may influence patients’ responses due to context
effect [28]. Second, analyses were based on cross-
sectional data, and hence causal inferences cannot be
made. Third, the EQ-5D was based on mapping, which is
suboptimal compared to the direct use of a preference-
based measure.
Table 1 Socio-demographic,
clinical, dialysis characteristics
and the HRQOL scores of the
patients
Total (n = 266) CAPD (n = 145) APD (n = 121) p value
Socio-demographic
Age, mean (SD) 59.3 (12.5) 60.8 (11.4) 57.4 (13.6) 0.03*
Young (45 years) 33 (12.4%) 15 (10.4%) 18 (14.9%) 0.13
Middle-aged (45–60 years) 90 (33.8%) 44 (30.3%) 46 (38.0%)
Old ([60 years) 143 (53.8%) 86 (59.3%) 57 (47.1%)
Gender 0.99
Male 121 (45.5%) 66 (45.5%) 55 (45.5%)
Female 145 (54.5%) 79 (54.5%) 66 (54.5%)
Ethnicity 0.76
Chinese 198 (74.4%) 109 (75.2%) 89 (73.6%)
Malay/Indian/others 68 (25.6%) 36 (24.8%) 32 (26.4%)
Educational level 0.02*
Low (no/primary/secondary) 215 (80.8%) 125 (86.2%) 90 (74.4%)
High (tertiary/above) 51 (19.2%) 20 (13.8%) 31 (25.6%)
Marital status 0.99
Married 189 (71.1%) 103 (71.0%) 86 (71.1%)
Other 77 (28.9%) 42 (29.0%) 35 (28.9%)
Housing type 0.13
Private residence 31 (11.7%) 13 (9.0%) 18 (14.9%)
Public residence 235 (88.3%) 132 (91.0%) 103 (85.1%)
Clinical
CCI 5.08 (1.67) 5.19 (1.48) 4.95 (1.87) 0.24
Albumin (g/l) 30.3 (5.6) 29.9 (5.2) 30.8 (6.0) 0.20
Hemoglobin (g/dl) 10.9 (1.69) 10.9 (1.67) 11.0 (1.71) 0.78
Dialysis
Dependency status \0.01**
Self-care 164 (61.6%) 102 (70.3%) 62 (51.2%)
Assisted 102 (38.4%) 43 (29.7%) 59 (48.8%)
Dialysis vintage (years) 3.55 (3.28) 4.50 (3.68) 2.42 (2.26) \0.001***
Dialysis adequacy
Kt/V (per week) 2.33 (0.88) 2.28 (0.72) 2.40 (1.04) 0.26
QOL scores
PCS 37.1 (9.8) 36.2 (9.6) 38.1 (9.7) 0.10
MCS 46.6 (11.1) 46.7 (11.2) 46.4 (11.1) 0.80
KDCS 58.7 (18.0) 57.6 (19.0) 60.0 (16.7) 0.29
Symptoms 72.6 (18.4) 69.8 (18.6) 76.0 (17.7) \0.01**
Effects 69.1 (21.0) 67.9 (21.4) 70.5 (20.4) 0.31
Burden 34.4 (26.9) 35.2 (27.8) 33.5 (25.8) 0.62
EQ-5D 0.59 (0.21) 0.58 (0.21) 0.60 (0.22) 0.35
APD automated peritoneal dialysis, CAPD continuous ambulatory peritoneal dialysis, CCI Charlson
Comorbidity Index, EQ-5D EuroQol 5-dimension, HRQOL health-related quality of life, KDCS kidney
disease component summary, MCS mental component summary, PCS physical component summary, QOL
quality of life, SD standard deviation
* p\ 0.05, ** p\ 0.01, *** p\ 0.001
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5 Conclusion
The HRQOL of CAPD and APD patients was largely
equivalent in Singapore, but APD patients seemed to
experience better physical health and be less bothered by
dialysis-related symptoms. In the context of increasing
advocacy for expanding PD utilization, more work is
necessary to evaluate the outcomes of PD modalities to
inform modality selection and guide healthcare resource
allocation.
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Table 2 Coefficients of the independent predictor variables for HRQOL scores in peritoneal dialysis patients
Independent variable Dependent variable
Component summary score KDCS subscale Health utility
PCS MCS KDCS Symptoms Effects Burden EQ-5D
Young (45 years) Ref.
Middle-aged (45–60 years) -5.31** 0.58 -2.44 -6.30 -2.46 1.44 -0.088
Old ([60 years) -2.81 2.69 4.58 0.95 6.97 5.83 -0.022
Male Ref.
Female 0.61 -1.01 1.97 0.33 3.39 2.18 -0.003
Chinese Ref.
Malay/Indians/others -2.56 0.77 -1.42 -0.81 -4.11 0.65 -0.039
Low education (no/primary/secondary) Ref.
High education (tertiary/above) -1.10 2.31 -1.49 -2.36 -4.42 2.32 0.007
Non-married Ref.
Married 1.23 -1.61 -2.90 -1.38 -3.81 -3.50 0.002
Housing type, public residence Ref.
Housing type, private residence 0.80 0.08 2.13 2.89 -3.01 9.10 0.006
Low CCI (\5) Ref.
High CCI (C5) -0.95 -1.32 -5.75 -2.28 -4.59 -10.4 -0.029
Low albumin level (\37 g/l) Ref.
High albumin level (C37 g/l) 5.75** 4.90* 6.38 7.52 10.7* 0.90 0.146**
Low hemoglobin level (\11 g/dl) Ref.
High hemoglobin level (C11 g/dl) 1.70 0.62 2.47 2.33 1.97 3.12 0.037
CAPD Ref.
APD 2.81* -0.56 2.63 6.90** 4.78 -3.78 0.039
Dependency status, assisted Ref.
Dependency status, self-care 5.12*** -0.20 2.79 4.50 6.03 -2.16 0.085**
Short dialysis vintage (\3.5 years) Ref.
Long dialysis vintage (C3.5 years) 0.02 0.42 -0.97 -1.66 0.31 -1.55 0.011
Low dialysis adequacy (\2.0/week) Ref.
High dialysis adequacy (C2.0/week) -1.63 -2.74 -1.69 -0.85 -2.53 -1.69 -0.065*
Total R2 0.17 0.05 0.06 0.09 0.08 0.04 0.15
All p values for a given independent variable are controlled for all other independent variables in the model
APD automated peritoneal dialysis, CAPD continuous ambulatory peritoneal dialysis, CCI Charlson Comorbidity Index, EQ-5D EuroQol
5-dimension, HRQOL health-related quality of life, KDCS kidney disease component summary, MCS mental component summary, PCS physical
component summary
* p\ 0.05, ** p\ 0.01, *** p\ 0.001
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